[Federal Register Volume 62, Number 247 (Wednesday, December 24, 1997)]
[Notices]
[Page 67377]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-33666]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Vaccine Advisory Committee (NVAC), Subcommittee on
Future Vaccines, Subcommittee on Immunization Coverage, and
Subcommittee on Vaccine Safety: Meetings
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following Federal advisory committee
meetings.
Name: National Vaccine Advisory Committee (NVAC).
Times and Dates: 9 a.m.-2 p.m., January 12, 1998. 8:30 a.m.-1:15
p.m., January 13, 1998.
Place: Hubert H. Humphrey Building, Room 800, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Notice: In the interest of security, the Department has
instituted stringent procedures for entrance to the Hubert H.
Humphrey Building by non-government employees. Thus, persons without
a government identification card should plan to arrive at the
building each day either between 8 and 8:30 a.m. or 12:30 and 1 p.m.
so they can be escorted to the meeting. Entrance to the meeting at
other times during the day cannot be assured.
Purpose: This committee advises and makes recommendations to the
Director of the National Vaccine Program on matters related to the
Program responsibilities.
Matters To Be Discussed: Agenda items will include updates on
the National Vaccine Program Office (NVPO) activities; the National
Vaccine Plan and NVAC's role in defining priorities for action;
unmet needs funding--past, present and future; adult immunization:
report of the workgroup; use of non-traditional sites for adult
immunization; influenza: a growing need for pandemic preparedness;
and a discussion on vaccines for international travel.
In addition, there will be updates on welfare reform and effects
on immunization; moving towards a Department of Health and Human
Services' vaccine safety action plan; work group on philosophical
exemptions--final report; the presidential initiative on
immunization registries; global use of critically needed vaccines--
strategies to consider. There will be reports from the Subcommittee
on Immunization Coverage, Subcommittee on Future Vaccines, and
Subcommittee on Vaccine Safety.
Name: Subcommittee on Immunization Coverage.
Time and Date: 2 p.m.-5 p.m., January 12, 1998.
Place: Hubert H. Humphrey Building, Room 423A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee will identify and propose solutions
that provide a multifaceted and holistic approach to reducing
barriers that result in low immunization coverage for children.
Matters To Be Discussed: This subcommittee will hold a
discussion on the review of recommendations from the document,
``Strategies to Sustain Immunization Coverage,'' and the
finalization of those recommendations.
Name: Subcommittee on Future Vaccines.
Time and Date: 2 p.m.-5 p.m., January 12, 1998.
Place: Hubert H. Humphrey Building, Room 405A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: The Subcommittee on Future Vaccines will develop policy
options and guide national activities which will lead to accelerated
development, licensure, and best use of new vaccines in the simplest
possible immunization schedules.
Matters To Be Discussed: This subcommittee will hold discussions
regarding the continued evaluation of methods to remove barriers to
development, licensure and use of safe and effective new vaccines;
combination vaccines, strategic options; and defining future
vaccines policy issues for travelers' vaccines.
Name: Subcommittee on Vaccine Safety.
Time and Date: 2 p.m.-5 p.m., January 12, 1998.
Place: Hubert H. Humphrey Building, Room 800, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee will review issues relevant to
vaccine safety and adverse reactions to vaccines.
Matters To Be Discussed: This subcommittee will hold discussions
regarding its goals; a report from the Task Force on Safer Childhood
Vaccines; a project report on benefit-risk communication curriculum
development; and agenda items for the next meeting.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Felecia D. Pearson,
Committee Management Specialist, NVPO, CDC, 1600 Clifton Road, NE,
M/S D50, Atlanta, Georgia 30333, telephone 404/639-4450.
Dated: December 19, 1997.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 97-33666 Filed 12-23-97; 8:45 am]
BILLING CODE 4163-18-P
